We observed a reduction in the phosphorylated PI3K-pathway proteins (pAKT and pmTOR) in ACC cells treated with BGT226 and STA9090, compared to PIK75-STA9090 treated ACC cells. This evidence concerns the gene PIK3CG and adrenal cortex carcinoma.